Your browser doesn't support javascript.
loading
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.
Ren, Shengxiang; Tian, Qinrui; Amar, Nadav; Yu, Hui; Rivard, Christopher J; Caldwell, Charles; Ng, Terry L; Tu, Megan; Liu, Yiwei; Gao, Dexiang; Ellison, Kim; Suda, Kenichi; Rozeboom, Leslie; Rivalland, Gareth; Mitchell, Paul; Zhou, Caicun; Hirsch, Fred R.
Afiliação
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Tian Q; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Amar N; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Yu H; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Rivard CJ; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Caldwell C; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Ng TL; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Tu M; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Department of Surgery (Urology), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Liu Y; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Gao D; Departments of Statistics, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Ellison K; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Suda K; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Rozeboom L; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Rivalland G; Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Studley Rd, Heidelberg, VIC, Australia.
  • Mitchell P; Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Studley Rd, Heidelberg, VIC, Australia.
  • Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Hirsch FR; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: fred.hirsch@ucdenver.edu.
Lung Cancer ; 125: 115-120, 2018 11.
Article em En | MEDLINE | ID: mdl-30429008
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Membro 14 de Receptores do Fator de Necrose Tumoral / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Membro 14 de Receptores do Fator de Necrose Tumoral / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Irlanda